Long-term follow-up of patients under omalizumab initiated during the pre-approval period in France

M. Molimard, P. Chanez, C. Pison, L. Tétu, V. Le Gros (Marseille, Grenoble, Toulouse, Rueil-Malmaison, France)

Source: Annual Congress 2010 - Management of airway disease
Session: Management of airway disease
Session type: Thematic Poster Session
Number: 4562
Disease area: Airway diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
M. Molimard, P. Chanez, C. Pison, L. Tétu, V. Le Gros (Marseille, Grenoble, Toulouse, Rueil-Malmaison, France). Long-term follow-up of patients under omalizumab initiated during the pre-approval period in France. Eur Respir J 2010; 36: Suppl. 54, 4562

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Clinical outcome in patients treated with omalizumab during pre-approval period in France
Source: Eur Respir J 2007; 30: Suppl. 51, 621s
Year: 2007

Long-term prognosis in rehabilitated COPD patients. A 3-year controlled study and a 3-year follow-up
Source: Eur Respir J 2001; 18: Suppl. 33, 224s
Year: 2001

Participation in scheduled asthma follow-up contacts and adherence to treatment during 12-year follow-up
Source: Virtual Congress 2021 – Primary care organisation and epidemiology
Year: 2021


Are SABA-reliant asthma patients receiving adequate ICS therapy? A nationwide cohort study in Sweden (HERA)
Source: International Congress 2019 – Asthma treatment: novel insights from clinical studies
Year: 2019


One-year follow-up of asthma patients in a randomised controlled trial of high-intensity training. Are there lasting effects?
Source: International Congress 2018 – Clinical markers of asthma
Year: 2018


A ten year follow-up of former paediatric asthma patients
Source: Eur Respir J 2005; 26: Suppl. 49, 233s
Year: 2005

The long-term effect of an exercise and diet intervention in asthma patients: a 1-year follow-up on a randomised controlled trial
Source: ERJ Open Res, 5 (2) 00032-2019; 10.1183/23120541.00032-2019
Year: 2019



A multicenter randomized trial for the effectiveness of structured discharge and follow-up protocol on readmission rate in COPD patients receiving LTOT/NIV: one-year interim analysis.
Source: International Congress 2018 – Hot topics in non-invasive ventilation
Year: 2018



Two-years of a community maintenance follow-up program in patients with COPD
Source: Annual Congress 2012 - The latest insights in pulmonary rehabilitation
Year: 2012

Long-term benefits of pulmonary rehabilitation in COPD patients: 2 year follow-up
Source: International Congress 2017 – Novel treatments for rehabilitation of patients with chronic respiratory diseases
Year: 2017

Time on therapy and concomitant medication use of mepolizumab in Canada: a retrospective cohort study
Source: ERJ Open Res, 7 (1) 00778-2020; 10.1183/23120541.00778-2020
Year: 2021



A longitudinal follow-up of severe asthma patients receiving reslizumab
Source: International Congress 2017 – Asthma management
Year: 2017


Stop omalizumab: a multicenter follow up study after discontinuation in pediatric patients with severe asthma
Source: Virtual Congress 2021 – Paediatric allergic asthma: novel therapeutics and monitoring approaches
Year: 2021


COPD patients under 50 years of age: 4-year follow-up in the UPLIFT trial
Source: Annual Congress 2009 - Functional insights into COPD
Year: 2009


Our clinical experience in surgical therapy of 272 patients with bronchiectasis during 15-year period
Source: Annual Congress 2008 - Pleuropulmonary infections; thoracic trauma
Year: 2008

The treatment with flunisolide in severe steroid asthmatics: the three-year follow-up study
Source: Eur Respir J 2001; 18: Suppl. 33, 47s
Year: 2001

Benefits of interferon-αcon-1 (IFN-αcon-1) as add-on therapy in patients with severe persistent asthma who are inadequately controlled despite best available therapy. Results of a 12-month prospective case-controlled study
Source: Eur Respir J 2006; 28: Suppl. 50, 439s
Year: 2006

Stability of FENO50 in a COPD cohort in Sweden over 2-year follow-up
Source: International Congress 2019 – FeNO in airway diseases and asthma-COPD overlap identification
Year: 2019

Discontinuation rates of omalizumab treatment in a cohort of severe asthmatics in Bulgaria
Source: International Congress 2019 – Real-world experience of monoclonal antibodies in asthma
Year: 2019


Long-term effectiveness of surgery treatment of TB patients
Source: Virtual Congress 2020 – Tuberculosis and adverse events in different populations
Year: 2020